| abstract |
Provided is a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease / disorder where modulation of chemokine receptor activity is beneficial. |